Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Novavax Files for Provisional Approval of its COVID-19 Vaccine in Australia 2021-10-29 19:15
Operating Income of Yiling Pharmaceutical in First 3 Quarters Reaches CNY 8.112 Billion, Up 25.81% 2021-10-29 17:17
Over Half of ASEAN Food & Agriculture Policymakers Note Climate Change as the Top Challenge Facing Regional Food Systems 2021-10-29 17:02
3M Health Care and Thermo Fisher Scientific Collaborate to Increase Process Efficiency and Scalability in Commercial Therapeutic Manufacturing 2021-10-29 15:45
Appendix 4C - Q1 FY22 Quarterly Cash Flow Report 2021-10-29 14:50
/DISREGARD RELEASE: Frontier Biotechnologies/ 2021-10-29 13:34
EZZ Marks Transition to Genomic Health Following Exceptional FY21 Performance 2021-10-29 04:05
Aiming for Global CDMO, Xcell Therapeutics opens an export route to 62 countries with cell therapy culture technology. 2021-10-28 21:00
Merck Drives New Innovation & Adds Capacity to Advance Next Generation Antibody-drug Conjugate (ADC) Therapies 2021-10-28 21:00
HanAll Biopharma Reports Third Quarter 2021 Results 2021-10-28 21:00
BioVaxys Further Expands Intellectual Property Portfolio in Global Markets 2021-10-28 20:00
Interim report for Q3 2021 : Bactiguard Holding AB (publ) 2021-10-28 15:23
WuXi Biologics Completes GMP Inspection by Health Canada for Drug Substance Facility 2021-10-28 08:30
Frontier Biotechnologies' Long-acting Injectable (Aikening(R)), In A Two Drug Regimen, Proves Safe And Effective For Critically Ill Hospitalized AIDS Patients 2021-10-27 22:08
Frontier Biotechnologies' Long-acting Injectable (Aikening(R)), In A Two Drug Regimen, Proves Safe And Effective For Critically Ill Hospitalized AIDS Patients 2021-10-27 22:06
Frontier Biotechnologies' Long-acting Injectable (Aikening(R)), In A Two Drug Regimen, Proves Safe And Effective For Critically Ill Hospitalized AIDS Patients 2021-10-27 22:03
Frontier Biotechnologies' Long-acting Injectable (Aikening(R)), In A Two Drug Regimen, Proves Safe And Effective For Critically Ill Hospitalized AIDS Patients 2021-10-27 21:25
Frontier Biotechnologies' Long-acting Injectable (Aikening(R)), in a Two Drug Regimen, Proves Safe and Effective for Critically Ill Hospitalized AIDS Patients 2021-10-27 20:47
Novavax Files for Authorization of its COVID-19 Vaccine in the United Kingdom 2021-10-27 20:30
Abcam completes $340m strategic acquisition and expands kit capacity and capability 2021-10-27 14:00
1 177 178 179 180 181 415